Evidence map›Paper›PMID 39095582›Full record

ArticleDrug delivery and translational research2024

Unlocking the potential of nanomedicine: advances in precision targeting strategies.

Christian Celia, Tambet Teesalu, Hélder A Santos

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christian CeliaDepartment of Pharmacy, University of Chieti- Pescara "G. d'Annunzio", 66100, Chieti I, Italy. c.celia@unich.it.
Tambet TeesaluLaboratory of Precision and Nanomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 14b, Tartu, 50090, Estonia. tambet.teesalu@ut.ee.
Hélder A SantosDepartment of Biomaterials and Biomedical Technology, The Personalized Medicine Research Institute Groningen (PRECISION), University Medical Center Groningen, University of Groningen, Groningen, 9713 AV, The Netherlands. h.a.santos@umcg.nl.ORCID 0000-0001-7850-6309

Funding

Eesti Teaduste Akadeemia PRG1788Eesti Teaduste Akadeemia PRG230EuronanomedIII ECM-CART and iNanoGunMinistero dell'Università e della Ricerca D54I19002790005Ministero dell'Università e della Ricerca D56C18000780005Overseas Visiting Fellow Program 2022, University of Shanghai, China Overseas Visiting Fellow Program 2022, University of Shanghai, ChinaTRANSCAN3 project ReachGLIO TRANSCAN3 project ReachGLIOUMCG Research Funds UMCG Research Funds
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Delivery SystemsNanomedicinePrecision MedicineHumansDrug targetingNanomedicineNanoparticlesPersonalized medicinePrecision medicine

Identifiers

PMID39095582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.